Outcome implications for the timing of bilateral total knee arthroplasties

M. Ritter, L. A. Mamlin, C. A. Melfi, Barry Katz, D. A. Freund, D. S. Arthur

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Health Care Financing Administration data from 1985 to 1990 revealed 339,152 total knee arthroplasties of which 62,730 (18.6%) were bilateral procedures (simultaneous 112,922; staged 6 weeks, 4354; staged 3 months, 4524; staged 6 months, 9829; and staged 1 year 31,401). Medicare beneficiaries undergoing bilateral procedures were an average of 73 years of age; demographics revealed that among the various simultaneous and staged groups 57% to 69% were females, 90% were white, 85% to 90% had a diagnosis of osteoarthritis, and 30% to 40% were performed in rural hospitals. Between 1985 and 1990, surgical and vascular complications ranged from 2.4% to 4% and 4.1% to 6.8%, respectively, for all types of bilateral staged and simultaneous total knee arthroplasties. All differences were statistically significant. After controlling statistically for demographic variables and diagnoses, a surrogate for case mix, it was found that individuals electing simultaneous bilateral arthroplasties experienced twice the number of intensive care days than those choosing staged procedures. Days in the intensive care unit were double when done simultaneously instead of staged (0.48 versus 0.21). Nosocomial infectious were similar within groups (10% versus 13%); however, wound infectious were nearly half when done simultaneously (0.5% versus 1%) versus in a staged fashion. Length of stay and cost were much less for the simultaneous procedure group who were sicker as measured by the number of diagnoses. Mortality at 30 days was highest for the simultaneous procedure group (.99%) versus staged 3 or 6 months (0.30%); however, by 2 years it was close to 4% for all groups. Staging the procedure 3 to 6 months seems to offer the fewest disadvantage, is only slightly more expensive, and has the lowest mortality rate.

Original languageEnglish
Pages (from-to)99-105
Number of pages7
JournalClinical Orthopaedics and Related Research
Issue number345
StatePublished - 1997

Fingerprint

Knee Replacement Arthroplasties
Demography
Centers for Medicare and Medicaid Services (U.S.)
Rural Hospitals
Mortality
Diagnosis-Related Groups
Critical Care
Medicare
Osteoarthritis
Arthroplasty
Blood Vessels
Intensive Care Units
Length of Stay
Costs and Cost Analysis
Wounds and Injuries

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Ritter, M., Mamlin, L. A., Melfi, C. A., Katz, B., Freund, D. A., & Arthur, D. S. (1997). Outcome implications for the timing of bilateral total knee arthroplasties. Clinical Orthopaedics and Related Research, (345), 99-105.

Outcome implications for the timing of bilateral total knee arthroplasties. / Ritter, M.; Mamlin, L. A.; Melfi, C. A.; Katz, Barry; Freund, D. A.; Arthur, D. S.

In: Clinical Orthopaedics and Related Research, No. 345, 1997, p. 99-105.

Research output: Contribution to journalArticle

Ritter, M, Mamlin, LA, Melfi, CA, Katz, B, Freund, DA & Arthur, DS 1997, 'Outcome implications for the timing of bilateral total knee arthroplasties', Clinical Orthopaedics and Related Research, no. 345, pp. 99-105.
Ritter, M. ; Mamlin, L. A. ; Melfi, C. A. ; Katz, Barry ; Freund, D. A. ; Arthur, D. S. / Outcome implications for the timing of bilateral total knee arthroplasties. In: Clinical Orthopaedics and Related Research. 1997 ; No. 345. pp. 99-105.
@article{019dd7ce72184916a5202b0cca44a3ee,
title = "Outcome implications for the timing of bilateral total knee arthroplasties",
abstract = "Health Care Financing Administration data from 1985 to 1990 revealed 339,152 total knee arthroplasties of which 62,730 (18.6{\%}) were bilateral procedures (simultaneous 112,922; staged 6 weeks, 4354; staged 3 months, 4524; staged 6 months, 9829; and staged 1 year 31,401). Medicare beneficiaries undergoing bilateral procedures were an average of 73 years of age; demographics revealed that among the various simultaneous and staged groups 57{\%} to 69{\%} were females, 90{\%} were white, 85{\%} to 90{\%} had a diagnosis of osteoarthritis, and 30{\%} to 40{\%} were performed in rural hospitals. Between 1985 and 1990, surgical and vascular complications ranged from 2.4{\%} to 4{\%} and 4.1{\%} to 6.8{\%}, respectively, for all types of bilateral staged and simultaneous total knee arthroplasties. All differences were statistically significant. After controlling statistically for demographic variables and diagnoses, a surrogate for case mix, it was found that individuals electing simultaneous bilateral arthroplasties experienced twice the number of intensive care days than those choosing staged procedures. Days in the intensive care unit were double when done simultaneously instead of staged (0.48 versus 0.21). Nosocomial infectious were similar within groups (10{\%} versus 13{\%}); however, wound infectious were nearly half when done simultaneously (0.5{\%} versus 1{\%}) versus in a staged fashion. Length of stay and cost were much less for the simultaneous procedure group who were sicker as measured by the number of diagnoses. Mortality at 30 days was highest for the simultaneous procedure group (.99{\%}) versus staged 3 or 6 months (0.30{\%}); however, by 2 years it was close to 4{\%} for all groups. Staging the procedure 3 to 6 months seems to offer the fewest disadvantage, is only slightly more expensive, and has the lowest mortality rate.",
author = "M. Ritter and Mamlin, {L. A.} and Melfi, {C. A.} and Barry Katz and Freund, {D. A.} and Arthur, {D. S.}",
year = "1997",
language = "English",
pages = "99--105",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "345",

}

TY - JOUR

T1 - Outcome implications for the timing of bilateral total knee arthroplasties

AU - Ritter, M.

AU - Mamlin, L. A.

AU - Melfi, C. A.

AU - Katz, Barry

AU - Freund, D. A.

AU - Arthur, D. S.

PY - 1997

Y1 - 1997

N2 - Health Care Financing Administration data from 1985 to 1990 revealed 339,152 total knee arthroplasties of which 62,730 (18.6%) were bilateral procedures (simultaneous 112,922; staged 6 weeks, 4354; staged 3 months, 4524; staged 6 months, 9829; and staged 1 year 31,401). Medicare beneficiaries undergoing bilateral procedures were an average of 73 years of age; demographics revealed that among the various simultaneous and staged groups 57% to 69% were females, 90% were white, 85% to 90% had a diagnosis of osteoarthritis, and 30% to 40% were performed in rural hospitals. Between 1985 and 1990, surgical and vascular complications ranged from 2.4% to 4% and 4.1% to 6.8%, respectively, for all types of bilateral staged and simultaneous total knee arthroplasties. All differences were statistically significant. After controlling statistically for demographic variables and diagnoses, a surrogate for case mix, it was found that individuals electing simultaneous bilateral arthroplasties experienced twice the number of intensive care days than those choosing staged procedures. Days in the intensive care unit were double when done simultaneously instead of staged (0.48 versus 0.21). Nosocomial infectious were similar within groups (10% versus 13%); however, wound infectious were nearly half when done simultaneously (0.5% versus 1%) versus in a staged fashion. Length of stay and cost were much less for the simultaneous procedure group who were sicker as measured by the number of diagnoses. Mortality at 30 days was highest for the simultaneous procedure group (.99%) versus staged 3 or 6 months (0.30%); however, by 2 years it was close to 4% for all groups. Staging the procedure 3 to 6 months seems to offer the fewest disadvantage, is only slightly more expensive, and has the lowest mortality rate.

AB - Health Care Financing Administration data from 1985 to 1990 revealed 339,152 total knee arthroplasties of which 62,730 (18.6%) were bilateral procedures (simultaneous 112,922; staged 6 weeks, 4354; staged 3 months, 4524; staged 6 months, 9829; and staged 1 year 31,401). Medicare beneficiaries undergoing bilateral procedures were an average of 73 years of age; demographics revealed that among the various simultaneous and staged groups 57% to 69% were females, 90% were white, 85% to 90% had a diagnosis of osteoarthritis, and 30% to 40% were performed in rural hospitals. Between 1985 and 1990, surgical and vascular complications ranged from 2.4% to 4% and 4.1% to 6.8%, respectively, for all types of bilateral staged and simultaneous total knee arthroplasties. All differences were statistically significant. After controlling statistically for demographic variables and diagnoses, a surrogate for case mix, it was found that individuals electing simultaneous bilateral arthroplasties experienced twice the number of intensive care days than those choosing staged procedures. Days in the intensive care unit were double when done simultaneously instead of staged (0.48 versus 0.21). Nosocomial infectious were similar within groups (10% versus 13%); however, wound infectious were nearly half when done simultaneously (0.5% versus 1%) versus in a staged fashion. Length of stay and cost were much less for the simultaneous procedure group who were sicker as measured by the number of diagnoses. Mortality at 30 days was highest for the simultaneous procedure group (.99%) versus staged 3 or 6 months (0.30%); however, by 2 years it was close to 4% for all groups. Staging the procedure 3 to 6 months seems to offer the fewest disadvantage, is only slightly more expensive, and has the lowest mortality rate.

UR - http://www.scopus.com/inward/record.url?scp=0031441151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031441151&partnerID=8YFLogxK

M3 - Article

SP - 99

EP - 105

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 345

ER -